We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$13.7B
AUM Growth
+$1.53B
Cap. Flow
+$732M
Cap. Flow %
5.35%
Top 10 Hldgs %
18.92%
Holding
125
New
6
Increased
86
Reduced
25
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 23.78%
2 Technology 19.36%
3 Financials 14.42%
4 Industrials 13.7%
5 Consumer Staples 13.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
1
Integra LifeSciences
IART
$1.41B
$354M 2.58%
6,066,660
+387,900
+7% +$23.1M
P
2
Everpure Inc
P
$23.5B
$284M 2.08%
16,613,360
+1,460,155
+10% +$25.8M
EG icon
3
Everest Group
EG
$15.8B
$277M 2.03%
1,001,590
+2,540
+0.3% +$670K
CTLT
4
DELISTED
CATALENT, INC.
CTLT
$273M 2%
4,851,205
+719,325
+17% +$36.7M
CMD
5
DELISTED
Cantel Medical Corporation
CMD
$244M 1.78%
3,439,750
+984,548
+40% +$71.4M
FTV icon
6
Fortive
FTV
$18.9B
$241M 1.76%
5,003,564
+59,284
+1% +$2.68M
ROK icon
7
Rockwell Automation
ROK
$50.3B
$240M 1.75%
1,183,320
-74,190
-6% -$13.7M
WAT icon
8
Waters Corp
WAT
$37.7B
$233M 1.71%
998,575
+15,355
+2% +$3.39M
AME icon
9
Ametek
AME
$53.9B
$227M 1.66%
2,280,805
+5,545
+0.2% +$525K
NEWR
10
DELISTED
New Relic, Inc.
NEWR
$214M 1.57%
3,260,600
+868,155
+36% +$56.4M
EW icon
11
Edwards Lifesciences
EW
$49.2B
$212M 1.55%
2,723,700
+11,490
+0.4% +$897K
WLY icon
12
John Wiley & Sons Class A
WLY
$2.85B
$211M 1.54%
4,354,755
+217,915
+5% +$10.1M
NDSN icon
13
Nordson
NDSN
$16.5B
$211M 1.54%
1,295,080
-207,705
-14% -$32.8M
AJG icon
14
Arthur J. Gallagher & Co
AJG
$69.1B
$210M 1.53%
2,200,825
+3,180
+0.1% +$291K
NOW icon
15
ServiceNow
NOW
$119B
$207M 1.51%
3,668,325
+1,834,725
+100% +$96.7M
BLKB icon
16
Blackbaud
BLKB
$1.95B
$207M 1.51%
2,601,290
-580
-0% -$48.6K
XRAY icon
17
Dentsply Sirona
XRAY
$2.77B
$205M 1.5%
3,614,605
+253,360
+8% +$14.1M
PANW icon
18
Palo Alto Networks
PANW
$257B
$202M 1.47%
5,228,700
+135,840
+3% +$5.14M
ULTA icon
19
Ulta Beauty
ULTA
$21.9B
$200M 1.46%
791,035
+257,305
+48% +$62.9M
WDAY icon
20
Workday
WDAY
$41.7B
$199M 1.45%
1,209,430
+177,775
+17% +$29.5M
LW icon
21
Lamb Weston
LW
$7.55B
$197M 1.44%
2,289,755
+20,520
+0.9% +$1.65M
IEX icon
22
IDEX
IEX
$17.1B
$197M 1.44%
1,142,910
+170,140
+17% +$27.5M
NTRS icon
23
Northern Trust
NTRS
$22B
$196M 1.43%
1,843,215
-230
-0% -$23.5K
SJM icon
24
J.M. Smucker
SJM
$13.6B
$196M 1.43%
1,880,100
+327,445
+21% +$34.7M
TECH icon
25
Bio-Techne
TECH
$11.2B
$190M 1.39%
3,470,700
+143,260
+4% +$7.52M

Similar funds

Champlain Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Champlain Investment Partners held 125 positions worth $13.7B, up 13% from $12.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners deployed $732M of net new capital in Q4 2019, opening 6 new positions and adding to 86 existing holdings. Its largest new stake was Clarivate: 4,962,155 shares worth $83.4M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Splunk Inc, an estimated $65.1M trimmed.

  • Champlain Investment Partners's largest Q4 2019 buy was Clarivate: 4,962,155 shares worth $83.4M.
  • Champlain Investment Partners added most to ServiceNow in Q4 2019, an estimated $96.7M increase.
  • Champlain Investment Partners's biggest Q4 2019 reduction was Splunk Inc, cutting an estimated $65.1M.
  • Champlain Investment Partners fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $188M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $13.7B portfolio in Q4 2019.
  • Champlain Investment Partners opened 6 new positions and closed 6 in Q4 2019.
  • Champlain Investment Partners's portfolio value rose 13% quarter-over-quarter to $13.7B.

Based on Champlain Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.